Larissa A Korde

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. pmc Multidisciplinary meeting on male breast cancer: summary and research recommendations
    Larissa A Korde
    Division of Medical Oncology, University of Washington, 825 Eastlake Ave, E MS G3 630, Seattle, WA 98109, USA
    J Clin Oncol 28:2114-22. 2010
  2. doi request reprint Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
    Larissa A Korde
    Division of Medical Oncology, Department of Medicine University of Washington Seattle Cancer Care Alliance, G3639, 825 Eastlake Ave, E, Seattle, WA 98109, USA
    Breast Cancer Res Treat 119:685-99. 2010
  3. pmc No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families
    Larissa A Korde
    Division of Medical Oncology, University of Washington Seattle Cancer Care Alliance, 825 Eastlake Ave, E, G3 630, Seattle, WA 98109, USA
    Breast Cancer Res Treat 125:169-73. 2011

Detail Information

Publications3

  1. pmc Multidisciplinary meeting on male breast cancer: summary and research recommendations
    Larissa A Korde
    Division of Medical Oncology, University of Washington, 825 Eastlake Ave, E MS G3 630, Seattle, WA 98109, USA
    J Clin Oncol 28:2114-22. 2010
    ..This international collaboration will also facilitate the future planning of clinical trials that can address essential questions in the treatment of male breast cancer...
  2. doi request reprint Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
    Larissa A Korde
    Division of Medical Oncology, Department of Medicine University of Washington Seattle Cancer Care Alliance, G3639, 825 Eastlake Ave, E, Seattle, WA 98109, USA
    Breast Cancer Res Treat 119:685-99. 2010
    ..Larger studies using the methods described here are necessary to fully evaluate gene expression changes in response to chemotherapy...
  3. pmc No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families
    Larissa A Korde
    Division of Medical Oncology, University of Washington Seattle Cancer Care Alliance, 825 Eastlake Ave, E, G3 630, Seattle, WA 98109, USA
    Breast Cancer Res Treat 125:169-73. 2011
    ..Although this is the largest prospective cohort yet assembled to address this important question, the number of breast cancer events is still relatively small...